Merck & Co’s Keytruda shows potential in head and neck cancer useMerck & Co might be able to find another use for its immunotherapy Keytruda in first line head Share XMerck & Co’s Keytruda shows potential in head and neck cancer usehttps://pharmaphorum.com/news/keytruda-shows-promise-first-line-skin-cancer-treatment/
